Insights from the ISPOR Panel on the European Health Data Space

By João L. Carapinha

November 13, 2023

The European Health Data Space (EHDS) represents a groundbreaking initiative by the European Commission, poised to advance healthcare data management across the EU. As discussed in the recent ISPOR Europe conference panel, the EHDS is much more than a tool for pharmacovigilance and retrospective cohort studies.

It’s a comprehensive framework designed to empower EU citizens with equitable access to healthcare data while ensuring data privacy and fostering participation in intellectual property creation.

The EHDS is set to enhance the digitalization of health records and propel research. It supports the efficient utilization of electronic healthcare records and deployment of artificial intelligence for data analysis.

This advancement is not only expected to deepen research capabilities but also to spur innovation and improve policy-making at all societal levels.

Key opportunities presented by the EHDS include increased access to data and the attractiveness of Europe as a hub for clinical research, ultimately translating into improved patient outcomes. However, the implementation of the EHDS is not without challenges. These include ensuring transparency and trust in data sharing, addressing patient willingness to opt into data sharing, and navigating data protection and privacy concerns.

A significant challenge lies in extending the scope of EHDS beyond existing laws and regulations, aiming to build a stronger health data network backed by EU member states’ support.

Furthermore, panelists highlighted the importance of evaluating the readiness of EU member states to participate in the EHDS. Cultural barriers were identified as a critical hurdle, as the EHDS requires substantial organizational changes to facilitate the sharing, storage, and availability of data to various users and the research community.

As the EHDS progresses, it will undergo continuous improvement, driven by feedback from users and researchers accessing the data. This initiative is not just a standalone project but an integral component of the broader European Union. It aligns with the European strategy for data, indicating a holistic approach to data management and utilization across various sectors in the EU, with health data being a priority area.

In summary, the European Health Data Space is an ambitious and transformative project. It holds the promise of reshaping the landscape of healthcare research, policy-making, and industry practices within the EU, setting a precedent for the rest of the world in healthcare data management and utilization.

Reference url

Recent Posts

Novartis Drug Discovery Innovation: Advancing Global Health Through Strategic R&D

By João L. Carapinha

February 26, 2026

Novartis drug discovery innovation is transforming global health through the Biomedical Research group's shift from siloed efforts to an integrated, patient-centric model targeting high-burden diseases in low- and middle-income countries (LMICs). Under Manju Ujjini, Head of Lead Discovery, key mi...
BIC LEN HIV Treatment: New Single-Tablet Regimen Shows Promising Results in ARTISTRY Trials
BIC/LEN HIV Treatment Maintains Suppression in Switch Studies Phase 3 results from Gilead Sciences' ARTISTRY-1 and ARTISTRY-2 trials, presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) an...
Novo Nordisk Announces Semaglutide Price Reduction to Improve Patient Access
Novo Nordisk Drives Semaglutide Price Reduction Novo Nordisk slashes the US semaglutide list price—or wholesale acquisition cost (WAC)—for Wegovy®, Ozempic®, and Rybelsus® to $675 per month across key doses, effective January 1, 2027....